39634 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 15
12:19 UTC
|
SYM
Symbotic
|
◎ Target | Robert Jamieson ★★★★★ #281 | Buy | C$75.00→ C$60.00-20.0% |
|
Sep 15
12:19 UTC
|
SRRK
Scholar Rock
|
◎ Target | Andres Y. Maldonado ★★★☆☆ #2091 | Buy | $65.00→ $70.00+7.7% |
|
Sep 15
12:19 UTC
|
SEI
Solaris Energy Infrastructure
|
◎ Target | Sean Milligan ★★☆☆☆ #2638 | Buy | $98.00→ $104.00+6.1% |
|
Sep 15
12:19 UTC
|
RBLX
Roblox
|
◎ Target | Clark Lampen ★★★★☆ #700 | Sell | $30.00→ $41.00+36.7% |
|
Sep 15
12:19 UTC
|
MTDR
Matador Resources
|
◎ Target | Tim Rezvan ★★☆☆☆ #2499 | Overweight | $68.00→ $73.00+7.4% |
|
Sep 15
12:19 UTC
|
EXOD
Exodus Movement
|
◎ Target | Andrew Harte ★★★☆☆ #1612 | Buy | $16.00→ $12.00-25.0% |
|
Sep 15
12:19 UTC
|
EOSE
Eos Energy Enterprises
|
◎ Target | Sean Milligan ★★☆☆☆ #2638 | Buy | $11.00→ $10.00-9.1% |
|
Sep 15
12:19 UTC
|
ELMT
Elmet Group
|
◎ Target | James Ricchiuti ★★★☆☆ #1576 | Buy | $21.00→ $25.00+19.0% |
|
Sep 15
12:19 UTC
|
PNR
Pentair
|
↑ Upgrade | Nigel Coe ★★☆☆☆ #2570 | Peer Perform→ Outperform | $91.00 |
|
Sep 15
12:19 UTC
|
NYT
New York Times
|
↑ Upgrade | Curry Baker ★★☆☆☆ #2615 | Neutral→ Buy | |
|
Sep 15
12:19 UTC
|
EVPL
Everplay Group
|
↑ Upgrade | firm only | Buy | GBX 460 |
|
Sep 15
12:19 UTC
|
CRDF
Cardiff Oncology
|
↑ Upgrade | Robert Burns ★☆☆☆☆ #2945 | Neutral→ Buy | |
|
Sep 15
12:19 UTC
|
AGL
Agilon Health
|
↑ Upgrade | Lance Wilkes ★★★★☆ #873 | Market Perform→ Outperform | $86.00→ $125.00+45.3% |
|
Sep 15
11:19 UTC
|
WPP
WPP
|
◎ Target | firm only | Buy | GBX 405→ GBX 470+16.0% |
|
Sep 15
11:19 UTC
|
WIZZ
Wizz Air
|
◎ Target | firm only | Hold | GBX 1,200→ GBX 1,000-16.7% |
|
Sep 15
11:19 UTC
|
NWG
NatWest Group
|
◎ Target | firm only | Neutral | GBX 790→ GBX 830+5.1% |
|
Sep 15
11:19 UTC
|
LLOY
Lloyds Banking Group
|
◎ Target | firm only | Neutral | GBX 121→ GBX 123+1.7% |
|
Sep 15
11:19 UTC
|
KIST
Kistos
|
◎ Target | firm only | Buy | GBX 325→ GBX 405+24.6% |
|
Sep 15
11:19 UTC
|
GSK
GSK
|
◎ Target | firm only | Hold | GBX 2,000→ GBX 2,200+10.0% |
|
Sep 15
11:19 UTC
|
DATA
GlobalData
|
◎ Target | firm only | Neutral | GBX 110→ GBX 90-18.2% |
|
Sep 15
11:19 UTC
|
DATA
GlobalData
|
◎ Target | firm only | Buy | GBX 105→ GBX 90-14.3% |
|
Sep 15
11:19 UTC
|
CER
Cerillion
|
◎ Target | firm only | Buy | GBX 1,400→ GBX 1,200-14.3% |
|
Sep 15
11:19 UTC
|
BARC
Barclays
|
◎ Target | firm only | Overweight | GBX 610→ GBX 620+1.6% |
|
Sep 15
11:19 UTC
|
IOCJY
Iochpe-Maxion
|
↓ Downgrade | firm only | Neutral | |
|
Sep 15
11:19 UTC
|
DATA
GlobalData
|
↓ Downgrade | firm only | Buy | GBX 98→ GBX 170+73.5% |
|
Sep 15
11:19 UTC
|
ASND
Ascendis Pharma A/S
|
↓ Downgrade | firm only | Outperform | $287.00 |
|
Sep 15
11:19 UTC
|
SEIC
SEI Investments
|
↑ Upgrade | firm only | Outperform | |
|
Sep 15
11:19 UTC
|
RMD
ResMed
|
↑ Upgrade | Craig Wong-Pan ★★★★☆ #704 | Sec→ r Perform ➝ Outperform | $262.00 |
|
Sep 15
11:19 UTC
|
PNR
Pentair
|
↑ Upgrade | Nigel Coe ★★☆☆☆ #2570 | Peer Perform→ Outperform | |
|
Sep 15
11:19 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | |
|
Sep 15
10:18 UTC
|
HMSO
Hammerson
|
◎ Target | firm only | Buy | GBX 448→ GBX 423-5.6% |
|
Sep 15
10:18 UTC
|
AZN
AstraZeneca
|
◎ Target | firm only | Buy | £160→ £150-6.2% |
|
Sep 15
10:18 UTC
|
SRRK
Scholar Rock
|
↓ Downgrade | Etzer Darout ★★★☆☆ #1262 | Overweight→ Cautious | |
|
Sep 15
10:18 UTC
|
CLLS
Cellectis
|
↓ Downgrade | firm only | Market Perform | |
|
Sep 15
10:18 UTC
|
ASND
Ascendis Pharma A/S
|
↓ Downgrade | firm only | Outperform | |
|
Sep 15
10:18 UTC
|
RMD
ResMed
|
↑ Upgrade | Craig Wong-Pan ★★★★☆ #704 | Sec→ r Perform ➝ Outperform | |
|
Sep 15
10:18 UTC
|
RLGT
Radiant Logistics
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Sep 15
10:18 UTC
|
ETSY
Etsy
|
↑ Upgrade | firm only | Market Perform→ Outperform | $90.00 |
|
Sep 15
10:18 UTC
|
BNTC
Benitec Biopharma
|
↑ Upgrade | firm only | Outperform | |
|
Sep 15
10:18 UTC
|
AZN
Astrazeneca
|
↑ Upgrade | firm only | Sell→ Hold | |
|
Sep 15
10:18 UTC
|
AGL
Agilon Health
|
↑ Upgrade | firm only | Outperform | $125.00 |
|
Sep 15
01:17 UTC
|
AAPL
Apple
|
◎ Target | firm only | Neutral | $290.00→ $300.00+3.4% |
|
Sep 15
00:17 UTC
|
VLO
Valero Energy
|
◎ Target | Justin Jenkins ★★★★★ #92 | Strong-Buy | $350.00→ $450.00+28.6% |
|
Sep 15
00:17 UTC
|
VLO
Valero Energy
|
◎ Target | Joe Laetsch ★★★★☆ #773 | Equal Weight | $255.00→ $411.00+61.2% |
|
Sep 15
00:17 UTC
|
TRN
Trainline
|
◎ Target | firm only | Buy | GBX 311→ GBX 333+7.1% |
|
Sep 15
00:17 UTC
|
TH
Target Hospitality
|
◎ Target | Angel Castillo ★★☆☆☆ #2426 | Overweight | $22.00→ $25.00+13.6% |
|
Sep 15
00:17 UTC
|
TCS
Tecsys
|
◎ Target | firm only | Outperform | C$40.00→ C$41.00+2.5% |
|
Sep 15
00:17 UTC
|
TCS
Tecsys
|
◎ Target | firm only | Outperform | C$40.00→ C$41.00+2.5% |
|
Sep 15
00:17 UTC
|
STZ
Constellation Brands
|
◎ Target | Kaumil Gajrawala ★☆☆☆☆ #3142 | Hold | $147.00→ $135.00-8.2% |
|
Sep 15
00:17 UTC
|
SRRK
Scholar Rock
|
◎ Target | Gary Nachman ★★★☆☆ #1202 | Strong-Buy | $65.00→ $72.00+10.8% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.